Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,727.09
(
0.41%
)
US TECH 100
24,166.40
(
0.63%
)
Dow Jones
47,091.48
(
0.31%
)
Brent Oil
100.56
(
2.29%
)
Bitcoin
74,681.60
(
-0.22%
)
News Focus
News Focus
Post# of 19309
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122790
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: gym gravity post# 1449

Friday, 11/03/2006 5:26:38 PM

Friday, November 03, 2006 5:26:38 PM

Post# of 19309
GG et al: Thrombomodulin is a bona fide competitor in DIC/sepsis. The private company developing it is Artisan Pharma, which is based in Framingham, Massachusetts of all places and has a Japanese connection.

They just raised $39M in a Series A private placement:
http://www.artisanpharma.net/pressReleasepdf.pdf

p.s. This is the link to the abstract you posted last week:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&l...

Dew

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now